Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia

Biol Pharm Bull. 2006 Apr;29(4):623-8. doi: 10.1248/bpb.29.623.

Abstract

In the present study, we studied the neuroprotective effects of berberry extract (BE) against ischemic damage and the temporal and spatial alterations of N-methyl-D-aspartate receptor type 1 (NR1) and NR2A/2B immunoreactivities in the gerbil hippocampal CA1 region after transient ischemia to examine anti-ischemic effects and its role in transient forebrain ischemia. In the vehicle-treated group, the percentage of cresyl violet positive pyramidal cells in the CA1 region was about 11.4% compared to the sham-operated group 4 d after ischemic insult. BE showed neuroprotective effects against ischemic damage after ischemia-reperfusion. In the BE-treated groups, about 60-75% of CA1 pyramidal cells were stained with cresyl violet 4 d after ischemic insult. We observed the percentage of berberine (7.45+0.85 mg/g in BE) by HPLC, which is active ingredient of BE. NR1 immunoreactivity in the stratum pyramidale of the CA1 region in the vehicle-treated group was significantly increased at 30 min after transient forebrain ischemia, while at this time the NR1 immunoreactivity in the BE-treated groups was significantly low compared to the vehicle-treated group. The pattern of NR2A/B immunoreactivity in the stratum pyramidale of the BE-treated group and its protein levels were similar to that in the vehicle-treated group after ischemic insult. These results suggest that BE has potent neuroprotective effects against ischemic damage via the reduction of NR1 activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzoxazines
  • Berberine / analysis
  • Berberine / pharmacology
  • Berberis / chemistry*
  • Blotting, Western
  • Cell Death / drug effects
  • Chromatography, High Pressure Liquid
  • Gerbillinae
  • Hippocampus / metabolism*
  • Hippocampus / pathology*
  • Immunohistochemistry
  • Indicators and Reagents
  • Ischemic Attack, Transient / metabolism*
  • Ischemic Attack, Transient / pathology*
  • Male
  • Neurons / pathology*
  • Neuroprotective Agents / pharmacology*
  • Oxazines
  • Plant Extracts / pharmacology
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Reference Standards

Substances

  • Benzoxazines
  • Indicators and Reagents
  • NR1 NMDA receptor
  • NR2A NMDA receptor
  • Neuroprotective Agents
  • Oxazines
  • Plant Extracts
  • Receptors, N-Methyl-D-Aspartate
  • Berberine
  • cresyl violet